Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Spectral Medical content from Baxter Invester Day 2022
View:
Post by SouthernTierTom on May 27, 2022 8:11am

Spectral Medical content from Baxter Invester Day 2022

I would look at the "full deck"..

Our mention starts on page 8 of 19.

Note the growth in our specific area and the many places where our "offerings" appear to "fit"

Enjoy..and do comment ; - )

https://s22.q4cdn.com/911189824/files/doc_downloads/2022/05/Baxter-%E2%80%93-Acute-Therapies-Clinical-Nutrition-Medication-Delivery.pdf
Comment by daviking on May 27, 2022 11:12am
VERY interesting: Near term launches! : Sepsis Diagnostic Endotoxin diagnostic that aids in sepsis risk assessment and PMX Sepsis Filter Exclusive distribution in U.S. / Canada of PMX sepsis filter Must be pretty confident that PMX is going to "pass the muster", to mention it as "Near Term" Don't see how our SIMI/DIMI fits in since they have a "Recent ...more  
Comment by Accountprince on May 27, 2022 11:18am
Thanks Tom - the presentation certainly highlights the PMX and EAA products.  I don't think Baxter would put them in as definitively as they show here if they weren't virtually certain of success.  Heather as well would want to maintain her credibility so would be reluctant to commit to anything that could come back to haunt her.  This is HUGE as it does validate some of the ...more  
Comment by mercedesman on May 27, 2022 2:06pm
Great find...and kudos to Tom ! I agree with all of your conclusions above Ap.  Huge validation. "tire kicking" in the medical diagnostic and device fields can take many forms including: years and years of negotiations (often as Trials progress) the provision of $ xxxxxx millions by the ultimate distributor/liscensee to the developer/Trial conductor, in order to secure ...more  
Comment by SouthernTierTom on Jun 02, 2022 1:49pm
Time to "Don" the hoodie and sunglasses pal .... cuz the "tell" of complicit-cie is kind of "over-whelming... ; - )   I was trying to remember the name of the other US OTC 25 cent stock Baxter mentioned during their invester day to both the "analysts" and of coarse also in their "invester deck" ... I just can't remember the name of the co ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities